Join us for a practical, nursing-focused session exploring frontline administration of Darzalex/Rd in multiple myeloma, including strategies for managing infusion-related reactions and key updates from the new MSAG position statement. The session will also feature a regional case study from Toowoomba, showcasing how a tele-oncology model can support expanded access to treatment administration closer to home.
The treatment landscape for patients with newly diagnosed multiple myeloma who are transplant-ineligible continues to evolve, creating new opportunities and challenges for nursing practice. As new first-line treatment options become available, nurses play a central role in safe administration, patient education, and ongoing monitoring over prolonged treatment durations.
This webinar will explore contemporary nursing considerations in the mangement of transplant-ineligible newly diagnosed multiple myeloma.
Through real-world experience, attendees will gain insight into how tele-oncology can improve patient travel burden while maintaing high quality nurse-led care.
Delivered with the support of:

Haematology Cancer Care Coordinator CNC, Toowoomba Base Hospital and RBWH


Myeloma Specialist Nurse, Myeloma Australia
Jonah is a Myeloma Specialist Nurse with Myeloma Australia and has 13 years of experience in haematology and stem cell transplantation across the inpatient, outpatient, and clinical trials settings. She is most passionate about providing clear communication, patient education, and supporting informed patient choice, with a strong focus on supportive cares and improving quality of life for people living with myeloma for their families.Please accept {{cookieConsents}} cookies to view this content